New research brings hope to head and neck cancer survivors with radiotherapy-induced dry mouth

A UCLH patient has received an innovative treatment for radiotherapy-induced dry mouth, an irreversible serious adverse effect of head and neck cancer radiotherapy that causes permanent impairment of talking and eating.

Researchers hope that the gene therapy, called AAV2-hAQP1, will significantly improve the lives of patients who survived oral and oropharyngeal cancer but developed persistent dry mouth (known as xerostomia) from irreversible radiation damage to the salivary glands.

Read more here….https://www.uclh.nhs.uk/news/new-research-brings-hope-head-and-neck-cancer-survivors-radiotherapy-induced-dry-mouth